Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    18843118 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
Condition: Type I Diabetes
Interventions: Drug: Maltodextrin;   Drug: Placebo GAD-alum;   Drug: Glutamic Acid Decarboxylase in alum formulation;   Drug: Gamma-Aminobutyric Acid
2 Terminated A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: rhGAD65;   Drug: Placebo
3 Completed Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: rhGAD65 formulated in Alhydrogel® (Diamyd®)

Study has passed its completion date and status has not been verified in more than two years.